Trials / Conditions / Chemically-Induced Disorders
Chemically-Induced Disorders
7 registered clinical trials studyying Chemically-Induced Disorders — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | Developing and Evaluating a Machine-Learning Opioid Overdose Prediction & Risk-Stratification Tool in Primary NCT06810076 | University of Pittsburgh | N/A |
| Recruiting | Optimizing Chronic Pain Care With Mindfulness and Chronic Pain Management Visits NCT06387290 | University of Utah | Phase 3 |
| Recruiting | GLP-1R Agonist Treatment for Opioid Use Disorder NCT06548490 | Milton S. Hershey Medical Center | Phase 2 |
| Active Not Recruiting | Study of the Safety and Feasibility of Psilocybin in Adults With Methamphetamine Use Disorder NCT05322954 | University of Wisconsin, Madison | Phase 1 |
| Withdrawn | An Open-Label Trial of Repetitive Transcranial Magnetic Stimulation for Opioid Use Disorder NCT04157062 | West Virginia University | N/A |
| Completed | Neuroimmune Dysfunction in Alcohol Use Disorder NCT04210713 | University of Maryland, Baltimore | Phase 1 |
| Completed | Study of Structural Imaging NCT02564991 | National Institute on Alcohol Abuse and Alcoholism (NIAAA) | — |